- Home
- LDWY vs PAVM Comparison
LDWY vs PAVM Comparison
Compare LDWY & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- PAVM
- Stock Information
- Founded
- LDWY 1990
- PAVM 2014
- Country
- LDWY United States
- PAVM United States
- Employees
- LDWY N/A
- PAVM N/A
- Industry
- LDWY Advertising
- PAVM Medical/Dental Instruments
- Sector
- LDWY Consumer Discretionary
- PAVM Health Care
- Exchange
- LDWY Nasdaq
- PAVM Nasdaq
- Market Cap
- LDWY 6.9M
- PAVM 8.1M
- IPO Year
- LDWY 1991
- PAVM 2016
- Fundamental
- Price
- LDWY $3.69
- PAVM $1.14
- Analyst Decision
- LDWY
- PAVM Strong Buy
- Analyst Count
- LDWY 0
- PAVM 1
- Target Price
- LDWY N/A
- PAVM $21.00
- AVG Volume (30 Days)
- LDWY 5.1K
- PAVM 43.3K
- Earning Date
- LDWY 11-29-2024
- PAVM 11-13-2024
- Dividend Yield
- LDWY N/A
- PAVM N/A
- EPS Growth
- LDWY N/A
- PAVM N/A
- EPS
- LDWY N/A
- PAVM 0.53
- Revenue
- LDWY $24,813,000.00
- PAVM $4,034,000.00
- Revenue This Year
- LDWY N/A
- PAVM $70.80
- Revenue Next Year
- LDWY N/A
- PAVM $298.02
- P/E Ratio
- LDWY N/A
- PAVM $2.16
- Revenue Growth
- LDWY N/A
- PAVM 166.27
- 52 Week Low
- LDWY $3.02
- PAVM $0.60
- 52 Week High
- LDWY $6.88
- PAVM $4.88
- Technical
- Relative Strength Index (RSI)
- LDWY 54.80
- PAVM 53.53
- Support Level
- LDWY $3.31
- PAVM $1.01
- Resistance Level
- LDWY $3.99
- PAVM $1.21
- Average True Range (ATR)
- LDWY 0.21
- PAVM 0.08
- MACD
- LDWY 0.02
- PAVM 0.01
- Stochastic Oscillator
- LDWY 44.87
- PAVM 65.00
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.